Seeking Alpha

MACK
  Merrimack Pharmaceuticals - NASDAQ

8/22/2014, 1:09 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
MACK vs. ETF Alternatives
Company Description
Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.
Sector: Healthcare
Industry: Biotechnology
Country: United States